05/15/2025 8:13 PM | NTN Buzztime (Subject) Ernexa Therapeutics Inc. (Subject) Ernexa Therapeutics Inc. (Subject) HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025 3:42 PM | NTN Buzztime (Subject) Ernexa Therapeutics Inc. (Subject) Ernexa Therapeutics Inc. (Subject) Konar Shameek (Filed by)
| Form SCHEDULE 13G | |
05/14/2025 7:39 PM | NTN Buzztime (Subject) Ernexa Therapeutics Inc. (Subject) Ernexa Therapeutics Inc. (Subject) IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 1:14 PM | NTN Buzztime (Subject) Ernexa Therapeutics Inc. (Subject) Ernexa Therapeutics Inc. (Subject) Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025 10:48 AM | Cherington Charles (Reporting) NTN Buzztime (Issuer) Ernexa Therapeutics Inc. (Issuer) Ernexa Therapeutics Inc. (Issuer)
| Form 4/A | |
04/29/2025 11:15 PM | NTN Buzztime (Filer) Ernexa Therapeutics Inc. (Filer) Ernexa Therapeutics Inc. (Filer)
| Form EFFECT | |
04/16/2025 3:30 PM | NTN Buzztime (Filer) Ernexa Therapeutics Inc. (Filer) Ernexa Therapeutics Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
04/14/2025 4:05 PM | NTN Buzztime (Filer) Ernexa Therapeutics Inc. (Filer) Ernexa Therapeutics Inc. (Filer)
| Form ARS | |
04/04/2025 9:54 AM | Cherington Charles (Reporting) NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 9:55 AM | Cherington Charles (Filed by) NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
04/03/2025 4:17 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
Get the Latest News and Ratings for NTN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NTN Buzztime and its competitors with MarketBeat's FREE daily newsletter.
|
04/03/2025 7:55 AM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2025 6:30 AM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/24/2025 3:30 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:20 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/05/2025 4:55 PM | Cherington Charles (Filed by) NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
02/14/2025 8:30 PM | NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) Singer Nicholas Jason (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 7:36 PM | NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 4:54 PM | NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 6:00 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Luther Sanjeev (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Cicala Peter (Reporting) NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Bristol James Arthur (Reporting) NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Wexler William A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 4:31 PM | NTN Buzztime (Subject) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025 4:00 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/14/2025 4:01 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/17/2024 11:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
11/14/2024 5:45 AM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/14/2024 5:45 AM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/05/2024 3:30 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/05/2024 11:42 AM | Cherington Charles (Reporting) NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form ARS | |
09/27/2024 3:47 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
09/27/2024 3:15 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:36 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
URGENT: Someone's Moving Gold Out of London... (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
09/23/2024 3:30 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 4:00 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:30 PM | NTN Buzztime (Filer) Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 3:32 PM | NTN Buzztime (Issuer) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |